Background: CIC is a transcriptional repressor inactivated by loss-of-function mutations in
Introduction
Capicua (CIC) is a transcriptional repressor that is mutated or rearranged in in several cancer types, including undifferentiated small round cell sarcomas 1 (~60% frequency), oligodendrogliomas 2,3 (~50-80%), gastric adenocarcinomas 4 (~9%), endometrial carcinomas 5 (~7%), and melanomas (~8%) 6, 7 . CIC loss has also been implicated in prostate cancer 8 , lung cancer 9 , and T-cell lymphoblastic leukemia/lymphoma 10, 11 . CIC alterations and/or loss of CIC activity have been associated with inferior outcomes [12] [13] [14] [15] and with aggressive phenotypes such as increased metastatic ability 9 and resistance to MAPK inhibitors 16, 17 , indicating that CIC likely functions as a tumour suppressor. Though functional studies of CIC are relatively limited in mammalian models, recent reports have shown that these oncogenic phenotypes appear to be due, at least in part, to de-repression of one or more of CIC's known target genes -which include the ETS transcription factors ETV1, ETV4, and ETV5 (ETV1/4/5) -upon loss of CIC [8] [9] [10] .
Chromosome instability (CIN) is a process that leads to whole-or partial-chromosome gains and losses and that results in aneuploidy, a cellular genetic state that is considered a hallmark of cancer 18 . Common mechanisms of aneuploid and polyploid cell formation (i.e. cells that contain more than two complete sets of chromosomes) include cytokinesis failure, which can for example be due to defects in cytokinetic proteins 19 , errors in chromosome segregation (CS) 20 , prolonged arrests at the spindle assembly checkpoint (SAC) 21, 22 , DNA replication errors 23 , and cell-cell fusion 24 .
Here, we describe a novel function of mammalian CIC in regulating cell cycle progression and CS, and show that loss of CIC is associated with CS defects and CIN, resulting in aneuploidy. We also find that CIC interacts with core members of the SWI/SNF complex, and
show that together they function to regulate the transcription of genes involved in cell cycle regulation and the SAC.
Results

1.
Nuclear CIC is subject to dynamic spatial and temporal re-distribution during the cell cycle.
To examine the spatial dynamics of nuclear CIC, we performed immunofluorescence (IF) assays in two neural cell lines: an immortalized normal human astrocyte line (NHA 25 ; Figure 1a ), and the HOG 26 line (Supplementary Figure 1) . We observed that CIC was dynamically redistributed over the course of the cell cycle in both cell lines. As shown in Figure 1a , CIC was found throughout the nucleus during interphase, but appeared to be excluded from condensed chromosomes at metaphase and telophase. During early cytokinesis, CIC foci appeared at decondensing chromosomes during initiation of nuclear envelope reassembly, and increasingly We confirmed this observation using an N-terminal-FLAG-tagged CIC-S construct (F-CIC-S) introduced into an isogenic CIC knockout (CIC KO ) cell line derived from HEK293A 27 (hereafter referred to as HEK F-CIC-S ). Ectopically expressed F-CIC-S displayed similar localization dynamics as endogenous CIC (Supplementary Figure 1) , indicating that both CIC isoforms were dynamically re-localized during mitotic phases, thus raising the possibility that some CIC functions may be related to the cell cycle.
Loss of CIC is associated with chromosomal segregation defects in human and mouse cells.
Motivated by the apparent dynamic association of CIC with chromosomes, and to explore the relationship between CIC function and the cell cycle, we performed IF assays on synchronized NHA-derived CIC KO cell lines 27 . We synchronized the parental NHA cell line and two of its derivative CIC KO cell lines (A2 and H9) at G2/M phase using the reversible cyclindependent kinase 1 (CDK1) inhibitor RO-3306 28 . The synchronized populations were then observed at 1h after drug removal ("post-release"), corresponding approximately to metaphase; To determine whether CIC deficiency was also associated with CS defects in vivo, we examined the appearance of mitotic chromosomes at the anaphase-to-telophase stages in a recently reported Cic conditional knockout mouse model 29 Figure 2) .
We next analyzed the DLP+ data to reveal the frequency and distribution of copy number segments in individual cells, where segments were defined as adjacent bins with identical copy number and neutral copy number was defined as an individual cell's determined ploidy state (Methods). While the CIC KO lines did not show consistent differences in the number of neutral segments or segments with copy number gain or loss compared to CIC WT cells (Figure 1g ), Figure 3) . Given that CCNB1 is a key regulator of mitotic progression, reduced CCNB1 through down-regulation of CCNB1 mRNA expression in mitotic CIC KO cells supports the notion that loss of CIC can result in delayed entry into metaphase.
Loss of CIC is associated with dysregulated expression of mitotic kinases and regulators of the spindle assembly checkpoint (SAC).
Defects in the SAC, which acts at the pro-metaphase-to-metaphase transition, and defective cytokinesis have both been associated with CS defects and resulting aneuploidy 36 . Expression of mitotic kinases and genes regulating the SAC are tightly controlled, with mRNA accumulation beginning in S-phase and peak mRNA levels occurring at the G2/M transition and throughout mitosis 37 . We thus hypothesized that mitotic kinases and regulators of the SAC might also display dysregulated expression in CIC KO To confirm that these mRNA expression changes were a consequence of CIC loss, we performed a rescue experiment in which we re-introduced CIC constructs into CIC KO cells and measured gene expression using RT-qPCR. Given that CIC exists in two isoforms -namely the long (CIC-L) and short (CIC-S) forms -and that we have previously shown these to have different patterns of distribution 38 , we re-introduced each isoform individually to examine their also showed a significant difference in expression upon re-introduction of CIC-L. While this could be an indirect consequence of CIC re-introduction, these results also raise the possibility that CIC may function as a transcriptional activator acting on these genes. Together, these observations are consistent with the notion that CIC-S, which is found both in the cytoplasm and the nucleus 38 , plays a significant role in the regulation of mitotic genes. The reduced expression of CCNB1, AURKA, BUB1, and PLK1 in CIC KO but not CIC WT cells is consistent with the notion that CIC loss leads to gene expression alterations that may delay mitotic progression, perhaps contributing to CIN.
To determine whether these novel candidate target genes might be direct targets of CIC regulation, we identified canonical CIC binding sites 39 within their promoter regions (Methods;
Supplementary Table 1 ) and performed targeted chromatin immunoprecipitation (ChIP) followed by qPCR for these sites in unsynchronized and synchronized (0 h post-release, G2/M) cells.
Other than the sites in the promoter regions of the known CIC target genes ETV4 and ETV5 (Figure 3e) , none of the sites tested showed enrichment compared to a negative control region (NCR) and compared to CIC KO cells (examples in Supplementary Figure 3 Figure 4 ).
The two sites tested for PLK3 and one of the sites tested for HMGA1 showed significant enrichment compared to CIC KO cells in the G2/M-enriched population (> 2-fold difference, p < 0.05; Figure 3e ). Taken together, these observations support the contention that PLK3 and HMGA1 may be direct targets of CIC regulation through interaction with non-canonical binding sites within their gene bodies.
Nuclear CIC interacts with core subunits of the SWI/SNF complex.
To gain further insight into CIC's nuclear interaction network, we performed 48 , and SIN3A 49 ) has previously been linked to CS defects, we hypothesized that CIC's apparent interaction with members of the SWI/SNF complex might be related to its cell cyclerelated functions.
To further explore the relationships between CIC and SWI/SNF complex members, we first performed reciprocal IPs to validate the interactions between endogenous CIC and SMARCA2, ARID1A, SMARCC1, and POLR2A in the NHA line (Figure 4b-e) , and between F-CIC-S and SMARCA2 and ARID1A in HEK cells (Supplementary Figure 5) . To identify common interactors between CIC and either SMARCA2 or ARID1A, we performed additional IP-MS experiments against ARID1A and SMARCA2 using whole-lysate preparations of NHA cells (Supplementary Figure 5) . These experiments identified 13 (ARID1A IP) and 11
(SMARCA2 IP) interactors that overlapped with candidate CIC interactors (Supplementary Table 4 ). In addition to CIC, ten proteins (ARID1A, ARID2, FMR1, MTA2, L3MBTL3, PBRM1, SIN3A, SMARCA2, SMARCC1, and POLR2A) were recurrently identified as common interactors in the IP experiments (i.e. they interacted with CIC, ARIDIA, and SMARCA2). were used with antibodies targeting ARID1A, SMARCA2, SMARCC1, or ARID2 (Figure 5a ).
The greatest signal was observed for ARID1A, followed by SMARCA2, perhaps indicating that CIC interacts with these two proteins more frequently than the other SWI/SNF proteins tested.
For all interactors tested, PLA signals were mostly observed in the nucleus during interphase and early cytokinesis, while during metaphase/telophase they were detected in cytoplasmic regions (example shown in Figure 5b for ARID1A). This is consistent with the IF co-localization observed for CIC, ARID1A, SMARCA2, and SMARCC1 over the course of the cell cycle, as described above. Our results thus indicate that CIC, ARID1A, SMARCA2, and SMARCC1 have similar spatial distributions in the nucleus over the course of the cell cycle, and that CIC is in close proximity to the SWI/SNF protein complex, with interactions peaking at early cytokinesis and at interphase. Our data are thus compatible with the notion that CIC functions with SWI/SNF complex proteins.
Loss of CIC and ARID1A cooperatively affect chromosome segregation.
Given that ARID1A and SMARCA2 are known to regulate CS 47 Figure 6b ), consistent with the notion that combined loss of CIC and ARID1A cooperatively increases CS defects to a degree sufficient to reduce cell viability.
We next sought to determine whether the candidate CIC target genes involved in cell cycle and SAC regulation that we identified in this study were co-regulated by CIC and ARID1A. In knockdown appears to cooperate with CIC deficiency to decrease cell viability, perhaps through an increase in CS defects.
Discussion
In this study, we use human cells and a mouse model to describe a novel role for mammalian CIC in regulating mitotic progression and chromosome stability. We show that CIC is dynamically re-distributed over the course of the cell cycle, and that its loss is associated with defects in metaphase alignment and CS both in vitro and in vivo. Using DLP+ and interphase FISH analysis of NHA-derived CIC KO cells, we show that these defects are associated with CIN and alterations in ploidy. We propose that these phenotypes result, at least in part, from the transcriptional dysregulation of genes involved in cell cycle regulation, which we observed upon loss of CIC ( Figure 7 ). For instance, overexpression of HMGA1 51, 52 or PLK3 53 , both of which our results supported as novel targets of CIC transcriptional repression, has been shown to induce mitotic arrest and apoptosis. Meanwhile, a decrease in CCNB1 levels, which we also observed in response to CIC loss, has been shown to contribute to polyploidization in response to DNA damage 54 .
We also show that CIC interacts with core members of the SWI/SNF complex, namely ARID1A, SMARCA2, and SMARCC1. This raises the intriguing possibility that CIC might function as a member of the SWI/SNF complex. Of these, ARID1A knockdown was found to cooperatively increase mitotic defects and reduce cell viability in CIC KO cells. We show that CIC and ARID1A cooperatively regulate the expression of genes involved in mitotic regulation, implying that this activity may be at least partially responsible for the defects observed in cells lacking both functional proteins ( Figure 7 ). The ARID1A and CIC genes are located on chromosomal arms 1p36.11 and 19q13.2, respectively, and are thus both subject to loss of heterozygosity (LOH) in 1p/19q co-deleted LGGs 2,3 . Although CIC is frequently mutated in these tumours and ARID1A mutations are common in other cancer types 55, 56 , only 0.02% (3/169) of 1p/19q co-deleted LGG cases from The Cancer Genome Atlas (TCGA) harbour mutations in these two genes 6, 7, 57 . This observation, together with our own results, indicates that the combined inactivation of CIC and ARID1A is associated with decreased cellular viability, and may not be compatible with proliferation of cancer cells. If the response we observed when both protein products are lost can be recapitulated in tumour contexts, such a synthetic lethal relationship could possibly be exploited in the context of therapy for tumours lacking either functional CIC or ARID1A.
Conclusions
Our study establishes a novel role for CIC in cell cycle regulation and accurate CS and shows that loss of CIC is associated with a disruption in these processes, resulting in aneuploidy.
We present evidence that these consequences are mediated through the transcriptional dysregulation of genes involved in cell cycle regulation and the SAC, including CCNB1 and the proposed novel CIC targets HMGA1 and PLK3. We also uncovered a previously unappreciated 
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